CCOc1ccc(C(c2c(O)cc(C)n(CCOC)c2=O)N2CCC(C)CC2)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?